CONFIDENTIAL August 1, 2024Financial Advisory Agreement • August 1st, 2024 • ZyVersa Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 1st, 2024 Company Industry JurisdictionThe purpose of this financial advisory agreement (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P.”) by ZyVersa Therapeutics, Inc. (the “Company”) to render Financial Services (as defined below) to the Company.
CONFIDENTIAL Aspira Women’s Health Inc. Attention: Nicole Sandford 12117 Bee Caves Road, Building III Suite 100 Austin, TX 78738Financial Advisory Agreement • July 31st, 2024 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJuly 31st, 2024 Company Industry JurisdictionThe purpose of this financial advisory agreement (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P.”) by Aspira Women’s Health Inc. (the “Company”) to render Financial Services (as defined below) to the Company.
July 3, 2024Financial Advisory Agreement • July 3rd, 2024 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 3rd, 2024 Company Industry JurisdictionThe purpose of this financial advisory agreement (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P.”) by CNS Pharmaceuticals, Inc. (the “Company”) to render Financial Services (as defined below) to the Company.
CONFIDENTIAL CNS Pharmaceuticals, Inc. Attention: Christopher Downs Suite 900 Houston, TX 77027Financial Advisory Agreement • June 26th, 2024 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 26th, 2024 Company Industry JurisdictionThe purpose of this financial advisory agreement (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P.”) by CNS Pharmaceuticals, Inc. (the “Company”) to render Financial Services (as defined below) to the Company.
CONFIDENTIAL CNS Pharmaceuticals, Inc. Attention: John Climaco Suite 900 Houston, TX 77027Financial Advisory Agreement • June 14th, 2024 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 14th, 2024 Company Industry JurisdictionThe purpose of this financial advisory agreement (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P.”) by CNS Pharmaceuticals, Inc. (the “Company”) to render Financial Services (as defined below) to the Company.
CONFIDENTIAL Vivos Therapeutics, Inc. Attention: Bradford K. Amman Littleton, CO 80120Financial Advisory Agreement • February 15th, 2024 • Vivos Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 15th, 2024 Company Industry JurisdictionThe purpose of this financial advisory agreement (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P.”) by Vivos Therapeutics, Inc. (the “Company”) to render Financial Services (as defined below) to the Company.